Schwartz GK - Search Results

1

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival.

Ku GY, Yuan J, Page DB, Schroeder SE, Panageas KS, Carvajal RD, Chapman PB, Schwartz GK, Allison JP, Wolchok JD. Ku GY, et al. Among authors: schwartz gk. Cancer. 2010 Apr 1;116(7):1767-75. doi: 10.1002/cncr.24951. Cancer. 2010. PMID: 20143434 Free PMC article.

2

A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.

Saltz L, Kemeny N, Schwartz G, Kelsen D. Saltz L, et al. Cancer. 1994 Aug 1;74(3):958-61. doi: 10.1002/1097-0142(19940801)74:3<958::aid-cncr2820740326>3.0.co;2-x. Cancer. 1994. PMID: 8039124 Clinical Trial.

3

Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.

Casper ES, Christman KL, Schwartz GK, Johnson B, Brennan MF, Bertino JR. Casper ES, et al. Among authors: schwartz gk. Cancer. 1993 Aug 1;72(3):766-70. doi: 10.1002/1097-0142(19930801)72:3<766::aid-cncr2820720321>3.0.co;2-z. Cancer. 1993. PMID: 8392904 Clinical Trial.

4

A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.

Schwartz GK, Christman K, Saltz L, Casper E, Quan V, Bertino J, Martin DS, Colofiore J, Kelsen D. Schwartz GK, et al. Cancer. 1996 Nov 1;78(9):1988-95. Cancer. 1996. PMID: 8909321 Clinical Trial.

5

Phase II trial of paclitaxel in patients with soft-tissue sarcoma.

Casper ES, Waltzman RJ, Schwartz GK, Sugarman A, Pfister D, Ilson D, Woodruff J, Leung D, Bertino JR. Casper ES, et al. Among authors: schwartz gk. Cancer Invest. 1998;16(7):442-6. doi: 10.3109/07357909809011697. Cancer Invest. 1998. PMID: 9774950 Clinical Trial.

6

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.

Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES. Fata F, et al. Among authors: schwartz gk. Cancer. 1999 Nov 15;86(10):2034-7. Cancer. 1999. PMID: 10570428 Clinical Trial.

7

Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trials.

Schwartz GK, Harstrick A, González Barón M. Schwartz GK, et al. Eur J Cancer. 1999 Mar;35 Suppl 1:S9-13. doi: 10.1016/s0959-8049(99)00042-8. Eur J Cancer. 1999. PMID: 10645208 Clinical Trial.

8

Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.

Kaubisch A, Schwartz GK. Kaubisch A, et al. Among authors: schwartz gk. Cancer J. 2000 Jul-Aug;6(4):192-212. Cancer J. 2000. PMID: 11038138 Review.

9

A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.

O'Reilly EM, Stuart KE, Sanz-Altamira PM, Schwartz GK, Steger CM, Raeburn L, Kemeny NE, Kelsen DP, Saltz LB. O'Reilly EM, et al. Among authors: schwartz gk. Cancer. 2001 Jan 1;91(1):101-5. doi: 10.1002/1097-0142(20010101)91:1<101::aid-cncr13>3.0.co;2-k. Cancer. 2001. PMID: 11148565 Clinical Trial.

10

Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer.

Schwartz GK, Bertino J, Kemeny N, Saltz L, Kelsen DK, Tong W, Welch M, Endres S, Dimery I. Schwartz GK, et al. Anticancer Drugs. 2004 Mar;15(3):219-27. doi: 10.1097/00001813-200403000-00005. Anticancer Drugs. 2004. PMID: 15014354 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters